B-hPVRIG mice

C57BL/6-Pvrigtm1(PVRIG)Bcgen/Bcgen • 110091

B-hPTK7 mice
B-hPVRIG/hTIGIT mice

B-hPVRIG mice

Product nameB-hPVRIG mice
Catalog number110091
Strain nameC57BL/6-Pvrigtm1(PVRIG)Bcgen/Bcgen
Strain backgroundC57BL/6
NCBI gene ID102640920
AliasesCD112R; C7orf15

on this page

  • Phenotypic analysis
  • Efficacy

Posters

View All

    Publication

      mRNA expression analysis
      Strain specific analysis of PVRIG gene expression in WT and B-hPVRIG mice by RT-PCR. Mouse Pvrig mRNA was detectable in splenocytes of wild-type (+/+). Human PVRIG mRNA was detectable only in B-hPVRIG mice (H/H) but not in wild type mice.
      Protein expression analysis
      PVRIG expression analysis in homozygous B-hPVRIG mice by western blot. Heart collected from wild type and homozygous B-hPVRIG mice (H/H) and analyzed by western blot with anti-PVRIG antibody. Mouse PVRIG was detectable in wild-type mice. Human PVRIG was detectable in homozygous B-hPVRIG mice. Anti-PVRIG antibody is crossly reactive with PVRIG in human and mice.
      Analysis of spleen leukocytes cell subpopulations in B-hPVRIG mice
      Analysis of spleen leukocyte subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hPVRIG mice (n=3, 8-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cells, B cells, NK cells, dendritic cells, granulocytes, monocytes and macrophages in homozygous B-hPVRIG mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hPVRIG in place of its mouse counterpart dose not change the overall development, differentiation or distribution of these cell types in spleen. Values are expressed as mean ± SEM.
      Analysis of spleen T cell subpopulations in B-hPVRIG mice
      Analysis of spleen T cell subpopulations by FACS. Splenocytes were isolated from female C57BL/6 and B-hPVRIG mice (n=3, 8-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for CD3+ T cell population and used for further analysis as indicated here. B. Results of FACS analysis. The percent of CD4+ T cells, CD8+ T cells and Treg cells in homozygous B-hPVRIG mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hPVRIG in place of its mouse counterpart does not change the overall development, differentiation or distribution of these T cell subtypes in spleen. Values are expressed as mean ± SEM.
      Analysis of blood leukocytes cell subpopulations in B-hPVRIG mice
      Analysis of blood leukocyte subpopulations by FACS. Blood cells were isolated from female C57BL/6 and B-hPVRIG mice (n=3, 8-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for the CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. Percent of T cells, B cells, NK cells, dendritic cells, granulocytes, monocytes and macrophages in homozygous B-hPVRIG mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hPVRIG in place of its mouse counterpart does not change the overall development, differentiation or distribution of these cell types in spleen. Values are expressed as mean ± SEM.
      Analysis of blood T cell subpopulations in B-hPVRIG mice
      Analysis of blood T cell subpopulations by FACS. Blood cells were isolated from female C57BL/6 and B-hPVRIG mice (n=3, 8-week-old). Flow cytometry analysis of the splenocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for CD3+ T cell population and used for further analysis as indicated here. B. Results of FACS analysis. The percent of CD4+ T cells, CD8+ T cells and Treg cells in homozygous B-hPVRIG mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hPVRIG in place of its mouse counterpart does not change the overall development, differentiation or distribution of these T cell subtypes in spleen. Values are expressed as mean ± SEM.
      Analysis of Lymph node leukocytes cell subpopulations in B-hPVRIG mice
      Analysis of lymph node leukocyte subpopulations by FACS. lymph node were isolated from female C57BL/6 and B-hPVRIG mice (n=3, 8- week-old) Flow cytometry analysis of the leukocytes was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live cells were gated for CD45+ population and used for further analysis as indicated here. B. Results of FACS analysis. The percent of T cells, B cells and NK cells in homozygous B-hPVRIG mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hPVRIG in place of its mouse counterpart does not change the overall development, differentiation or distribution of these cell types in lymph node. Values are expressed as mean ± SEM.
      Analysis of Lymph node T cell subpopulations in B-hPVRIG mice
      Analysis of lymph node T cell subpopulations by FACS. lymph node were isolated from female C57BL/6 and B-hPVRIG mice (n=3, 8-week-old). Flow cytometry analysis of the lymph node was performed to assess leukocyte subpopulations. A. Representative FACS plots. Single live CD45+ cells were gated for CD3+ T cell population and used for further analysis as indicated here. B. Results of FACS analysis. The percent of CD4+ T cells, CD8+ T cells and Treg cells in homozygous B-hPVRIG mice were similar to those in the C57BL/6 mice, demonstrating that introduction of hPVRIG in place of its mouse counterpart does not change the overall development, differentiation or distribution of these T cell subtypes in spleen. Values are expressed as mean ± SEM.
      In vivo efficacy of anti-human PVRIG antibodies
      Antitumor activity of anti-human PVRIG antibodies in B-hPVRIG mice. (A) COM-701 (in house) and SRF-813 (in house) inhibited MC38 tumor growth in B-hPVRIG mice. Murine colon cancer MC38 cells were subcutaneously implanted into homozygous B-hPVRIG mice (female, 6-week-old, n=5). Mice were grouped when tumor volume reached approximately 100 mm3, at which time they were treated with COM-701 (in house) and SRF-813 (in house) with doses and schedules in panel A. (B) Body weight changes during treatment. As shown in panel A, anti-human PVRIG antibodies were efficacious in controlling tumor growth in B-hPVRIG mice, demonstrating that the B-hPVRIG mice provide a powerful preclinical model for in vivo evaluation of anti-human PVRIG antibodies. Values are expressed as mean ± SEM.